JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

Search

NeoGenomics Inc

Închisă

5.61 -1.06

Rezumat

Modificarea prețului

24h

Curent

Minim

5.54

Maxim

5.86

Indicatori cheie

By Trading Economics

Venit

-11M

-26M

Vânzări

-4M

168M

Marjă de profit

-15.427

Angajați

2,200

EBITDA

-10M

-6.3M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+80.04% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

-451M

831M

Deschiderea anterioară

6.67

Închiderea anterioară

5.61

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

NeoGenomics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

4 aug. 2025, 16:50 UTC

Principalele dinamici ale pieței

Verb Technology Shares Double After Private Placement, Intent to Buy Cryptocurrency

31 iul. 2025, 20:58 UTC

Câștiguri

Coinbase Global Misses on 2Q Revenue, Outlook

31 iul. 2025, 20:37 UTC

Câștiguri

MicroStrategy Swings to 2Q Profit on Bitcoin Gains

29 iul. 2025, 17:53 UTC

Principalele dinamici ale pieței

ZOOZ Shares Down; Plans $180 Million Private Placement for Bitcoin Reserve Strategy

29 iul. 2025, 16:36 UTC

Principalele dinamici ale pieței

Antelope Enterprise Shares Drop After Securities Purchase Agreement

28 iul. 2025, 19:37 UTC

Principalele dinamici ale pieței

Coinbase Shares Extend Declines for Sixth Day

4 aug. 2025, 08:37 UTC

Market Talk

Bitcoin Recovers as U.S. Rate-Cut Bets Rise -- Market Talk

1 aug. 2025, 22:31 UTC

Câștiguri

MicroStrategy Stock Drops 9%. New Equity Guidelines Could Be the Reason. -- Barrons.com

1 aug. 2025, 08:22 UTC

Market Talk

Bitcoin Falls to Three-Week Low After Tariff News, Ahead of U.S. Data -- Market Talk

31 iul. 2025, 21:26 UTC

Câștiguri

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

31 iul. 2025, 20:43 UTC

Câștiguri

Riot Platforms 2Q Produced 1,426 Bitcoin, as Compared to 844 During the Same 3-Mo Period in 2024 >RIOT

31 iul. 2025, 20:43 UTC

Câștiguri

Riot Platforms 2Q Rev $153M >RIOT

31 iul. 2025, 20:31 UTC

Câștiguri

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

31 iul. 2025, 15:30 UTC

Câștiguri

What MicroStrategy Earnings Tell Us About the Current State of Crypto Mania -- Barrons.com

31 iul. 2025, 15:20 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Coinbase Reports Earnings This Afternoon. What to Watch. -- Barrons.com

31 iul. 2025, 07:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

31 iul. 2025, 07:36 UTC

Market Talk

Bitcoin Modestly Higher But Stays Below Key $120,000 Level -- Market Talk

30 iul. 2025, 07:28 UTC

Market Talk

Bitcoin Edges Higher But Remains Stuck in a Range -- Market Talk

29 iul. 2025, 21:45 UTC

Market Talk
Câștiguri

Visa Views Stablecoin as Growth Opportunity -- Market Talk

29 iul. 2025, 21:21 UTC

Câștiguri

Visa CEO: U.S. Spend Growth Remained Strong in 2Q, No Noticeable Effects From Tariff

29 iul. 2025, 21:19 UTC

Câștiguri

Visa CEO: Consumers Have Used Visa to Spend $25B in Cryptocurrencies Since 2020

29 iul. 2025, 21:17 UTC

Câștiguri

Visa Is Best Way to Spend Money Using Stablecoins, CEO Says

29 iul. 2025, 21:17 UTC

Câștiguri

Visa CEO: We Support Genius Act, Believe Stablecoins Can Solve Problems for Certain Use Cases

29 iul. 2025, 17:38 UTC

Principalele dinamici ale pieței

ZOOZ Shares Down; Plans $180M Private Placement for Bitcoin Reserve Strategy

29 iul. 2025, 14:05 UTC

Câștiguri

SoFi Stock Pops on Outlook Raise as Members Keep Piling In -- Update

29 iul. 2025, 12:09 UTC

Market Talk

Stablecoin Regulation Could Support Dollar -- Market Talk

29 iul. 2025, 09:43 UTC

Market Talk

Ethereum Could Rise Further on Corporate Treasury Purchases -- Market Talk

29 iul. 2025, 08:24 UTC

Market Talk

Bitcoin Rises Slightly After U.S.-EU Trade Deal -- Market Talk

28 iul. 2025, 14:44 UTC

Achiziții, Fuziuni, Preluări

Anthony Pompliano's ProCap BTC LLC and Columbus Circle Cap Corp I Amend Business Combination Agreement to Provide Columbus Circle Cap Corp I Public Hldrs With Opportunity for Bitcoin Appreciation

28 iul. 2025, 08:19 UTC

Market Talk

Bitcoin Inches Higher After U.S., EU Reach Tariff Agreement -- Market Talk

Comparație

Modificare preț

NeoGenomics Inc Așteptări

Obiectiv de preț

By TipRanks

80.04% sus

Prognoză pe 12 luni

Medie 9.29 USD  80.04%

Maxim 12 USD

Minim 8 USD

În baza a 11 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruNeoGenomics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

11 ratings

4

Cumpărare

7

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

7.7 / 10.27Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

Bearish Evidence

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.